Guzman: Factors associated with increased mortality in critically ill COVID-19 patients in a Mexican public hospital: the other faces of health system oversaturation

Guzman, ivermectin late treatment study: 19% lower mortality [p=0.35] https://c19p.org/guzman

copied to clipboard

Factors associated with increased mortality in critically ill COVID-19 patients in a Mexican public hospital: the other faces of health system oversaturation

Guzman et al., medRxiv, doi:10.1101/2021.03.04.21252084 (Preprint), NCT04391127 (history)

8 Mar 2021 Source PDF Share Tweet

Retrospective 196 critically ill patients in Mexico. Patients overlap with the existing RCT by Beltran-Gonzalez (NCT04391127 (history)). This preprint shows a larger treated population and greater (non-statistically significant) improvement with ivermectin, RR 0.81 [0.53-1.24].

Important missing comments or errors? Let us know.

risk of death, 19.0% lower, HR 0.81, p = 0.35.

Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates

Guzman et al., 8 Mar 2021, retrospective, Mexico, preprint, 11 authors, trial NCT04391127 (history).

All Studies Meta Analysis Submit Updates or Corrections

This Paper Ivermectin All

Late treatment
is less effective

Please send us corrections, updates, or comments. Vaccines and treatments are both valuable and complementary. All practical, effective, and safe means should be used. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. Denying the efficacy of any method increases mortality, morbidity, collateral damage, and the risk of endemic status. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.

Submit